©2022 PCMA. All Rights Reserved.
Thanks to PBMs’ efforts to give patients an incentive to use them and pharmacies an incentive to purchase them at the lowest prices, generics are widely available and affordable for hundreds of millions of Americans.
Using data from CMS, we see increases in the average plan contract-level beneficiary adherence to hypertension medication. Gains in adherence translates to real people staying on their medications and having better health outcomes.
This blog introduces a new series of blog posts that will look at interesting trends using the CMS’s historical Part D Star Ratings data, focusing on four measures of prescription drug adherence.
The Pharmacy Benefit Brief | April 2022
Covering effective drugs for the broad range of health care needs is critical. PBMs and health plan sponsors rely on the recommendations of Pharmacy and Therapeutics. . .
The Pharmacy Benefit Brief | February 2022
There is a growing trend in states to establish prescription drug affordability boards in an effort to control costs. But there are two important points that legislators must consider before going down this path.
Senior Vice President,
Assistant Vice President,
PCMA’s SmartBrief is a daily collection of news highlights for the PBM Industry. Below are a few from today.
Stay up to date on all of the latest news within the industry.
Pharmacy Benefit Managers (PBMs) are your advocates in the health care system, working to lower prescription drug costs for patients and payers across the country.
PBMs are working to help 266 million patients get the prescriptions they need during the pandemic. Better access. Better Cost. Better Health.